Extrawell Pharmaceutical Holdings Limited (HKG:0858)

HKG:0858 Balance Sheet

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	94.11	93.61	102.4	111.88	126.71	126.44
Short-Term Investments	2.74	0.74	0.75	0.74	0.75	0.9
Trading Asset Securities	773.59	0.66	1.75	1.91	1.79	1.65
Cash & Short-Term Investments	870.44	95.01	104.91	114.52	129.24	128.99
Cash Growth	808.52%	-9.43%	-8.40%	-11.39%	0.19%	-14.84%
Accounts Receivable	7.38	4.22	5.8	7.81	9.13	10.48
Other Receivables	34.46	34.92	36.51	36.28	42.01	38.87
Receivables	41.84	52.56	47.49	44.09	51.14	49.36
Inventory	2.61	7.27	3.02	8.47	7.56	5.87
Prepaid Expenses	-	1.13	2.54	1.4	0.8	0.78
Other Current Assets	19.88	21.47	20.71	25.91	22.34	24.11
Total Current Assets	934.77	177.44	178.66	194.38	211.08	209.1
Property, Plant & Equipment	126.24	126.04	136.54	148.39	143.56	140.08
Long-Term Investments	313.57	974.81	1,110	955.27	790.34	897.96
Goodwill	1.81	1.81	1.81	1.81	1.81	1.81
Long-Term Deferred Tax Assets	0.07	0.07	0.07	0.07	0.07	0.07
Other Long-Term Assets	2.35	2.42	2.55	2.68	1.26	1.32
Total Assets	1,399	1,287	1,445	1,317	1,164	1,266
Accounts Payable	4.94	4.66	6.63	6.46	6.69	6.24
Accrued Expenses	19.42	20.39	21.49	24.08	21.75	22.07
Current Portion of Leases	1.43	1.38	1.32	2.19	1.77	1.69
Current Income Taxes Payable	19.42	18.1	16.43	17.2	15.41	14.23
Current Unearned Revenue	3.69	6.61	6.61	6.87	5.16	3.92
Other Current Liabilities	1.08	0.24	4.53	7.26	7.12	10.18
Total Current Liabilities	49.97	51.37	57.01	64.06	57.89	58.33
Long-Term Debt	127.64	117.12	98.62	83.07	69.98	58.95
Long-Term Leases	1.11	1.91	3.29	0.04	2.12	3.89
Long-Term Unearned Revenue	4.21	4.17	4.38	5	4.95	4.69
Total Liabilities	182.93	174.58	163.3	152.18	134.95	125.86
Common Stock	23.9	23.9	23.9	23.9	23.9	23.9
Additional Paid-In Capital	196.58	196.58	196.58	196.58	196.58	196.58
Retained Earnings	548.98	448.04	610.99	481.73	351.14	472.24
Treasury Stock	-3.24	-3.24	-	-	-	-
Comprehensive Income & Other	450.26	447.84	450.25	463.45	458.89	449.78
Total Common Equity	1,216	1,113	1,282	1,166	1,031	1,142
Minority Interest	0.05	-0.51	-0.15	-0.73	-1.21	-2.65
Shareholders' Equity	1,217	1,113	1,282	1,165	1,029	1,140
Total Liabilities & Equity	1,399	1,287	1,445	1,317	1,164	1,266
Total Debt	130.18	120.41	103.22	85.31	73.87	64.54
Net Cash (Debt)	740.26	-25.4	1.68	29.22	55.37	64.46
Net Cash Growth	-	-	-94.24%	-47.23%	-14.10%	-36.70%
Net Cash Per Share	0.26	-0.01	0.00	0.01	0.02	0.02
Filing Date Shares Outstanding	2,390	2,390	2,390	2,390	2,390	2,390
Total Common Shares Outstanding	2,390	2,390	2,390	2,390	2,390	2,390
Working Capital	884.8	126.07	121.65	130.32	153.19	150.76
Book Value Per Share	0.51	0.47	0.54	0.49	0.43	0.48
Tangible Book Value	1,215	1,111	1,280	1,164	1,029	1,141
Tangible Book Value Per Share	0.51	0.46	0.54	0.49	0.43	0.48
Buildings	-	120.17	122.84	136.49	137.58	127.46
Machinery	-	61.42	55.61	52.77	49.4	45.31
Construction In Progress	-	0.09	6.01	7.89	-	-

Updated Dec 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.